Successful Treatment of Gemcitabine Toxicity with a Brief Course of Oral Corticosteroid Therapy

Chest

Volumn 114, Issue 6, 1998, Pages 1779-1781

  Vander, Nicholas J ^a,b   Miller, Vincent ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE   (United States)

Author keywords

Capillary leak syndrome; Corticosteroid therapy; gemcitabine; Non small cell lung cancer; Pulmonary infiltrates

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; GLUCOCORTICOID; PREDNISOLONE; RIBONUCLEOTIDE REDUCTASE;

ADENOCARCINOMA; ARTICLE; CASE REPORT; DRUG ANTAGONISM; FEMALE; HUMAN; LUNG TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; PLEURA TUMOR; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; FEMALE; GLUCOCORTICOIDS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PLEURAL NEOPLASMS; PREDNISOLONE; RIBONUCLEOTIDE REDUCTASES; TREATMENT OUTCOME;

EID: 0032247298     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.6.1779     Document Type: Article

References (5)

1. Pavlakis N, Bell DR, Millward MJ, et al. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 1997; 80:286-291
2. Nelson R, Tarasoff P. Dyspnea with gemcitabine is commonly seen, often disease related, transient and rarely severe [abstract]. Eur J Cancer 1995; 31(suppl 15):S197-S198
3. Carmichael J, Possinger K, Phillip P, et al. Advanced breast cancer: a phase II trial with gemcitabine. J Clin Oncol 1995; 13:2731-2736
4. Cooper JAD, White DA, Matthay RA. State of the art: drug-induced pulmonary disease. Part I: Cytotoxic drugs. Am Rev Respir Dis 1986; 133:321-340
5. Rosenow EC, Meyers JL, Swensen SJ, et al. Drug-induced pulmonary disease: an update. Chest 1992; 102:239-250